Goh AMY, Wibawa P, Loi SM, Walterfang M, Velakoulis D, Looi JCL. Huntington’s disease: neuropsychiatric manifestations of Huntington’s disease. Australas Psychiatry. 2018;26:366–75.

Article  PubMed  Google Scholar 

Bhattacharyya KB. The story of George Huntington and his disease. Ann Indian Acad Neurol. 2016;19:25–8.

Article  PubMed  PubMed Central  Google Scholar 

Waldvogel HJ, Kim EH, Tippett LJ, Vonsattel J‑PG, Faull RLM. The neuropathology of Huntington’s disease. In: Behav Neurobiol Huntington’s Dis Park Dis. 2015. pp. 33–80.

Google Scholar 

Ranganathan M, Kostyk SK, Allain DC, Race JA, Daley AM. Age of onset and behavioral manifestations in Huntington’s disease: an enroll-HD cohort analysis. Clin Genet. 2021;99:133–42.

Article  CAS  PubMed  Google Scholar 

Raza C, Anjum R, Shakeel ul NA. Parkinson’s disease: Mechanisms, translational models and management strategies. Life Sci [internet]. 2019;226:77–90.

Article  CAS  PubMed  Google Scholar 

Anjum R. Neuroprotective role of traditional Chinese plant extracts on Parkinson’s disease; a comprehensive preclinical review. Pharmacol Res—mod Chin Med [internet]. 2025;14:100573.

Article  Google Scholar 

Alzheimer’s Disease AR. Pathogenesis, Hypothesis and Management. Punjab Univ J Zool. 2023;38:229–36.

Google Scholar 

Datta N. Molecular Mechanisms and Clinical Features of Huntington Disease: A Fatal Neurodegenerative Disorder with Autosomal Dominant Inheritance. Columbia Undergrad Sci J. 2023;17:17–34.

Article  Google Scholar 

Bourn D, Bourn D. Autosomal Dominant Inheritance and Huntington Disease. In: Diagnostic Genet Test Core Concepts Wider Context Hum DNA Anal. 2022. pp. 23–35.

Google Scholar 

Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Prim. 2015;1:1–21.

Google Scholar 

Bakels HS, Roos RAC, van Roon-Mom WMC, de Bot ST. Juvenile-onset Huntington disease pathophysiology and neurodevelopment: a review. Mov Disord. 2022;37:16–24.

Article  PubMed  Google Scholar 

Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC. Group P-HI of the HS. Psychiatric symptoms in Huntington’s disease before diagnosis: the predict-HD study. Biol Psychiatry. 2007;62:1341–6.

Article  PubMed  Google Scholar 

Victorson D, Carlozzi NE, Frank S, Beaumont JL, Cheng W, Gorin B, et al. Identifying motor, emotional-behavioral, and cognitive deficits that comprise the Triad of HD Symptoms from patient, caregiver, and provider perspectives. Tremor Other Hyperkinetic Movements. 2014;4.

Dorsey ER, Beck CA, Darwin K, Nichols P, Brocht AFD, Biglan KM, et al. Natural history of Huntington disease. JAMA Neurol. 2013;70:1520–30.

PubMed  Google Scholar 

Rosenblatt A, Liang K‑Y, Zhou H, Abbott MH, Gourley LM, Margolis RL, et al. The association of CAG repeat length with clinical progression in Huntington disease. Neurology. 2006;66:1016–20.

Article  CAS  PubMed  Google Scholar 

Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol. 2013;12:637–49.

Article  PubMed  Google Scholar 

Papoutsi M, Labuschagne I, Tabrizi SJ, Stout JC. The cognitive burden in Huntington’s disease: pathology, phenotype, and mechanisms of compensation. Mov Disord. 2014;29:673–83.

Article  PubMed  Google Scholar 

Sellers J, Ridner SH, Claassen DO. A systematic review of neuropsychiatric symptoms and functional capacity in Huntington’s disease. J Neuropsychiatry Clin Neurosci. 2020;32:109–24.

Article  PubMed  Google Scholar 

Tabrizi SJ, Schobel S, Gantman EC, Mansbach A, Borowsky B, Konstantinova P, et al. A biological classification of Huntington’s disease: the Integrated Staging System. Lancet Neurol. 2022;21:632–44.

Article  PubMed  Google Scholar 

Lanciego JL, Luquin N, Obeso JA. Functional neuroanatomy of the basal ganglia. Cold Spring Harb Perspect Med. 2012;2:a9621.

Article  PubMed  PubMed Central  Google Scholar 

Hickman RA, Faust PL, Marder K, Yamamoto A, Vonsattel J‑P. The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade. acta neuropathol commun. 2022;10:55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rather MA, Khan A, Javed H, Jahan S, Tabassum R, Begum R. Neuropathology of neurological disorders. In: Mech Genet Susceptibility Neurol Disord Springer; 2024. pp. 1–33.

Google Scholar 

Nelson AB, Kreitzer AC. Reassessing models of basal ganglia function and dysfunction. Annu Rev Neurosci. 2014;37:117–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang A, Handley RR, Lehnert K, Snell RG. From pathogenesis to therapeutics: a review of 150 years of Huntington’s disease research. Int J Mol Sci. 2023;24:13021.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anjum R, Raza C, Faheem M, Ullah A, Chaudhry M. Neuroprotective potential of Mentha piperita extract prevents motor dysfunctions in mouse model of Parkinson’s disease through anti-oxidant capacities. Plos One [internet]. 2024;19:e302102. https://doi.org/10.1371/journal.pone.0302102.

Article  CAS  PubMed  Google Scholar 

Xu H, Ajayan A, Langen R, Chen J. Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington’s disease. Neurobiol Dis. 2025;205:106780.

Article  CAS  PubMed  Google Scholar 

Sawant N, Morton H, Kshirsagar S, Reddy AP, Reddy PH. Mitochondrial abnormalities and synaptic damage in Huntington’s disease: a focus on defective mitophagy and mitochondria-targeted therapeutics. Mol Neurobiol. 2021; 1–28.

Sharma A, Behl T, Sharma L, Aelya L, Bungau S. Mitochondrial dysfunction in Huntington’s disease: pathogenesis and therapeutic opportunities. Curr Drug Targets. 2021;22:1637–67.

Article  CAS  PubMed  Google Scholar 

Donaldson J, Powell S, Rickards N, Holmans P, Jones L. What is the pathogenic CAG expansion length in Huntington’s disease? J Huntingtons Dis. 2021;10:175–202.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vater M, Rost N, Eckstein G, Sauer S, Tontsch A, Erhardt A, et al. Huntingtin CAG repeat size variations below the Huntington’s disease threshold: associations with depression, anxiety and basal ganglia structure. Eur J Hum Genet. 2024; 1–9.

Pengo M, Squitieri F. Beyond CAG Repeats: The Multifaceted Role of Genetics in Huntington Disease. Genes (basel). 2024;15:807.

Article  CAS  PubMed  Google Scholar 

Almeida LM, Oliveira Â, Oliveira JMA, Pinho BR. Stress response mechanisms in protein misfolding diseases: Profiling a cellular model of Huntington’s disease. Arch Biochem Biophys. 2023;745:109711.

Article  CAS  PubMed  Google Scholar 

Andhale R, Shrivastava D. Huntington’s disease: a clinical review. Cureus. 2022;14.

Pogoda A, Chmielewska N, Maciejak P, Szyndler J. Transcriptional dysregulation in Huntington’s disease: the role in pathogenesis and potency for pharmacological targeting. Curr Med Chem. 2021;28:2783–806.

Article  CAS  PubMed  Google Scholar 

Chang C‑P, Wu C‑W, Chern Y. Metabolic dysregulation in Huntington’s disease: Neuronal and glial perspectives. Neurobiol Dis. 2024; 106672.

Henningsen JB, Soylu-Kucharz R, Björkqvist M, Petersén Å. Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease. Heliyon. 2021;7.

Saba J, Couselo FL, Bruno J, Carniglia L, Durand D, Lasaga M, et al. Neuroinflammation in Huntington’s disease: a starring role for astrocyte and microglia. Curr Neuropharmacol. 2022;20:1116.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pressl C, Mätlik K, Kus L, Darnell P, Luo J‑D, Paul MR, et al. Selective vulnerability of layer 5a corticostriatal neurons in Huntington’s disease. Neuron. 2024;112:924–41.

Article  CAS  PubMed  Google Scholar 

Fienko S, Landles C, Sathasivam K, McAteer SJ, Milton RE, Osborne GF, et al. Alternative processing of human HTT mRNA with implications for Huntington’s disease therapeutics. Brain. 2022;145:4409–24.

Article  PubMed  PubMed Central  Google Scholar 

Geijtenbeek KW, Janzen J, Bury AE, Sanz-Sanz A, Hoebe RA, Bondulich MK, et al. Reduction in PA28αβ activation in HD mouse brain correlates to increased mHTT aggregation in cell models. PLoS ONE. 2022;17:e278130.